nodes	percent_of_prediction	percent_of_DWPC	metapath
Benzphetamine—Tamoxifen—pancreatic cancer	0.518	1	CrCtD
Benzphetamine—POR—Doxorubicin—pancreatic cancer	0.0699	0.487	CbGbCtD
Benzphetamine—Toremifene—Tamoxifen—pancreatic cancer	0.037	0.114	CrCrCtD
Benzphetamine—Naftifine—Tamoxifen—pancreatic cancer	0.0306	0.0947	CrCrCtD
Benzphetamine—Methadyl Acetate—Tamoxifen—pancreatic cancer	0.0246	0.076	CrCrCtD
Benzphetamine—Levomethadyl Acetate—Tamoxifen—pancreatic cancer	0.0246	0.076	CrCrCtD
Benzphetamine—Cyclobenzaprine—Tamoxifen—pancreatic cancer	0.0231	0.0715	CrCrCtD
Benzphetamine—Doxylamine—Tamoxifen—pancreatic cancer	0.0213	0.0657	CrCrCtD
Benzphetamine—CYP2B6—Tamoxifen—pancreatic cancer	0.0213	0.148	CbGbCtD
Benzphetamine—Phenoxybenzamine—Tamoxifen—pancreatic cancer	0.0202	0.0624	CrCrCtD
Benzphetamine—Dextropropoxyphene—Tamoxifen—pancreatic cancer	0.0202	0.0624	CrCrCtD
Benzphetamine—Tripelennamine—Tamoxifen—pancreatic cancer	0.0192	0.0594	CrCrCtD
Benzphetamine—Bromodiphenhydramine—Tamoxifen—pancreatic cancer	0.018	0.0555	CrCrCtD
Benzphetamine—Methadone—Tamoxifen—pancreatic cancer	0.0169	0.0522	CrCrCtD
Benzphetamine—CYP2B6—Irinotecan—pancreatic cancer	0.0163	0.114	CbGbCtD
Benzphetamine—Clofedanol—Tamoxifen—pancreatic cancer	0.0146	0.0451	CrCrCtD
Benzphetamine—Orphenadrine—Tamoxifen—pancreatic cancer	0.0141	0.0437	CrCrCtD
Benzphetamine—Promazine—Tamoxifen—pancreatic cancer	0.0135	0.0417	CrCrCtD
Benzphetamine—Benzyl Benzoate—Tamoxifen—pancreatic cancer	0.0131	0.0404	CrCrCtD
Benzphetamine—Diphenhydramine—Tamoxifen—pancreatic cancer	0.0125	0.0388	CrCrCtD
Benzphetamine—CYP2B6—Doxorubicin—pancreatic cancer	0.00891	0.0621	CbGbCtD
Benzphetamine—CYP3A4—Tamoxifen—pancreatic cancer	0.00653	0.0455	CbGbCtD
Benzphetamine—CYP3A4—Erlotinib—pancreatic cancer	0.00555	0.0387	CbGbCtD
Benzphetamine—CYP3A4—Irinotecan—pancreatic cancer	0.00501	0.0349	CbGbCtD
Benzphetamine—CYP3A4—Docetaxel—pancreatic cancer	0.00367	0.0256	CbGbCtD
Benzphetamine—CYP3A4—Sunitinib—pancreatic cancer	0.00366	0.0255	CbGbCtD
Benzphetamine—CYP3A4—Doxorubicin—pancreatic cancer	0.00274	0.0191	CbGbCtD
Benzphetamine—Cardiomyopathy—Sunitinib—pancreatic cancer	0.000654	0.0675	CcSEcCtD
Benzphetamine—Cardiomyopathy—Fluorouracil—pancreatic cancer	0.000516	0.0533	CcSEcCtD
Benzphetamine—Cardiomyopathy—Epirubicin—pancreatic cancer	0.000251	0.0259	CcSEcCtD
Benzphetamine—Cardiomyopathy—Doxorubicin—pancreatic cancer	0.000232	0.024	CcSEcCtD
Benzphetamine—Sweating—Tamoxifen—pancreatic cancer	0.00021	0.0216	CcSEcCtD
Benzphetamine—Sweating—Irinotecan—pancreatic cancer	0.000148	0.0153	CcSEcCtD
Benzphetamine—Sweating—Gemcitabine—pancreatic cancer	0.000144	0.0149	CcSEcCtD
Benzphetamine—Hyperhidrosis—Tamoxifen—pancreatic cancer	0.000135	0.0139	CcSEcCtD
Benzphetamine—Anorexia—Tamoxifen—pancreatic cancer	0.000133	0.0137	CcSEcCtD
Benzphetamine—Anorexia—Erlotinib—pancreatic cancer	0.000131	0.0136	CcSEcCtD
Benzphetamine—Insomnia—Tamoxifen—pancreatic cancer	0.000126	0.013	CcSEcCtD
Benzphetamine—Insomnia—Erlotinib—pancreatic cancer	0.000125	0.0129	CcSEcCtD
Benzphetamine—Dyspepsia—Tamoxifen—pancreatic cancer	0.000123	0.0127	CcSEcCtD
Benzphetamine—Dyspepsia—Erlotinib—pancreatic cancer	0.000121	0.0125	CcSEcCtD
Benzphetamine—Decreased appetite—Tamoxifen—pancreatic cancer	0.000121	0.0125	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Tamoxifen—pancreatic cancer	0.00012	0.0124	CcSEcCtD
Benzphetamine—Decreased appetite—Erlotinib—pancreatic cancer	0.00012	0.0124	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Erlotinib—pancreatic cancer	0.000119	0.0123	CcSEcCtD
Benzphetamine—Anorexia—Sunitinib—pancreatic cancer	0.000114	0.0118	CcSEcCtD
Benzphetamine—Urticaria—Tamoxifen—pancreatic cancer	0.000111	0.0114	CcSEcCtD
Benzphetamine—Insomnia—Sunitinib—pancreatic cancer	0.000108	0.0112	CcSEcCtD
Benzphetamine—Dyspepsia—Sunitinib—pancreatic cancer	0.000105	0.0109	CcSEcCtD
Benzphetamine—Decreased appetite—Sunitinib—pancreatic cancer	0.000104	0.0107	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.000103	0.0106	CcSEcCtD
Benzphetamine—Hypersensitivity—Tamoxifen—pancreatic cancer	0.000103	0.0106	CcSEcCtD
Benzphetamine—Diarrhoea—Tamoxifen—pancreatic cancer	9.54e-05	0.00985	CcSEcCtD
Benzphetamine—Hyperhidrosis—Irinotecan—pancreatic cancer	9.51e-05	0.00982	CcSEcCtD
Benzphetamine—Diarrhoea—Erlotinib—pancreatic cancer	9.44e-05	0.00974	CcSEcCtD
Benzphetamine—Anorexia—Irinotecan—pancreatic cancer	9.37e-05	0.00968	CcSEcCtD
Benzphetamine—Hyperhidrosis—Gemcitabine—pancreatic cancer	9.26e-05	0.00956	CcSEcCtD
Benzphetamine—Dizziness—Tamoxifen—pancreatic cancer	9.22e-05	0.00952	CcSEcCtD
Benzphetamine—Tachycardia—Fluorouracil—pancreatic cancer	9.19e-05	0.00949	CcSEcCtD
Benzphetamine—Anorexia—Gemcitabine—pancreatic cancer	9.13e-05	0.00943	CcSEcCtD
Benzphetamine—Dizziness—Erlotinib—pancreatic cancer	9.12e-05	0.00942	CcSEcCtD
Benzphetamine—Anorexia—Fluorouracil—pancreatic cancer	8.98e-05	0.00927	CcSEcCtD
Benzphetamine—Insomnia—Irinotecan—pancreatic cancer	8.9e-05	0.00918	CcSEcCtD
Benzphetamine—Hypersensitivity—Sunitinib—pancreatic cancer	8.8e-05	0.00908	CcSEcCtD
Benzphetamine—Headache—Tamoxifen—pancreatic cancer	8.73e-05	0.00902	CcSEcCtD
Benzphetamine—Insomnia—Gemcitabine—pancreatic cancer	8.66e-05	0.00895	CcSEcCtD
Benzphetamine—Dyspepsia—Irinotecan—pancreatic cancer	8.66e-05	0.00894	CcSEcCtD
Benzphetamine—Headache—Erlotinib—pancreatic cancer	8.64e-05	0.00892	CcSEcCtD
Benzphetamine—Decreased appetite—Irinotecan—pancreatic cancer	8.55e-05	0.00883	CcSEcCtD
Benzphetamine—Insomnia—Fluorouracil—pancreatic cancer	8.52e-05	0.0088	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Irinotecan—pancreatic cancer	8.49e-05	0.00877	CcSEcCtD
Benzphetamine—Decreased appetite—Gemcitabine—pancreatic cancer	8.33e-05	0.0086	CcSEcCtD
Benzphetamine—Dyspepsia—Fluorouracil—pancreatic cancer	8.29e-05	0.00856	CcSEcCtD
Benzphetamine—Nausea—Tamoxifen—pancreatic cancer	8.28e-05	0.00855	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	8.27e-05	0.00854	CcSEcCtD
Benzphetamine—Nausea—Erlotinib—pancreatic cancer	8.19e-05	0.00846	CcSEcCtD
Benzphetamine—Decreased appetite—Fluorouracil—pancreatic cancer	8.19e-05	0.00845	CcSEcCtD
Benzphetamine—Diarrhoea—Sunitinib—pancreatic cancer	8.17e-05	0.00844	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	8.13e-05	0.0084	CcSEcCtD
Benzphetamine—Dizziness—Sunitinib—pancreatic cancer	7.9e-05	0.00815	CcSEcCtD
Benzphetamine—Urticaria—Fluorouracil—pancreatic cancer	7.48e-05	0.00773	CcSEcCtD
Benzphetamine—Headache—Sunitinib—pancreatic cancer	7.48e-05	0.00772	CcSEcCtD
Benzphetamine—Palpitations—Docetaxel—pancreatic cancer	7.36e-05	0.0076	CcSEcCtD
Benzphetamine—Hypersensitivity—Irinotecan—pancreatic cancer	7.25e-05	0.00748	CcSEcCtD
Benzphetamine—Nausea—Sunitinib—pancreatic cancer	7.09e-05	0.00732	CcSEcCtD
Benzphetamine—Hypersensitivity—Fluorouracil—pancreatic cancer	6.94e-05	0.00717	CcSEcCtD
Benzphetamine—Sweating—Epirubicin—pancreatic cancer	6.89e-05	0.00712	CcSEcCtD
Benzphetamine—Diarrhoea—Irinotecan—pancreatic cancer	6.73e-05	0.00695	CcSEcCtD
Benzphetamine—Tachycardia—Docetaxel—pancreatic cancer	6.64e-05	0.00685	CcSEcCtD
Benzphetamine—Diarrhoea—Gemcitabine—pancreatic cancer	6.55e-05	0.00677	CcSEcCtD
Benzphetamine—Dizziness—Irinotecan—pancreatic cancer	6.5e-05	0.00672	CcSEcCtD
Benzphetamine—Anorexia—Docetaxel—pancreatic cancer	6.48e-05	0.00669	CcSEcCtD
Benzphetamine—Diarrhoea—Fluorouracil—pancreatic cancer	6.44e-05	0.00665	CcSEcCtD
Benzphetamine—Sweating—Doxorubicin—pancreatic cancer	6.38e-05	0.00659	CcSEcCtD
Benzphetamine—Dizziness—Fluorouracil—pancreatic cancer	6.23e-05	0.00643	CcSEcCtD
Benzphetamine—Headache—Irinotecan—pancreatic cancer	6.16e-05	0.00636	CcSEcCtD
Benzphetamine—Insomnia—Docetaxel—pancreatic cancer	6.15e-05	0.00635	CcSEcCtD
Benzphetamine—Headache—Gemcitabine—pancreatic cancer	6e-05	0.0062	CcSEcCtD
Benzphetamine—Dyspepsia—Docetaxel—pancreatic cancer	5.98e-05	0.00618	CcSEcCtD
Benzphetamine—Decreased appetite—Docetaxel—pancreatic cancer	5.91e-05	0.0061	CcSEcCtD
Benzphetamine—Headache—Fluorouracil—pancreatic cancer	5.9e-05	0.00609	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Docetaxel—pancreatic cancer	5.87e-05	0.00606	CcSEcCtD
Benzphetamine—Nausea—Irinotecan—pancreatic cancer	5.84e-05	0.00603	CcSEcCtD
Benzphetamine—Nausea—Gemcitabine—pancreatic cancer	5.69e-05	0.00588	CcSEcCtD
Benzphetamine—Nausea—Fluorouracil—pancreatic cancer	5.59e-05	0.00578	CcSEcCtD
Benzphetamine—Agitation—Epirubicin—pancreatic cancer	5.16e-05	0.00533	CcSEcCtD
Benzphetamine—Hypersensitivity—Docetaxel—pancreatic cancer	5.01e-05	0.00517	CcSEcCtD
Benzphetamine—Palpitations—Epirubicin—pancreatic cancer	4.97e-05	0.00513	CcSEcCtD
Benzphetamine—Agitation—Doxorubicin—pancreatic cancer	4.78e-05	0.00493	CcSEcCtD
Benzphetamine—Diarrhoea—Docetaxel—pancreatic cancer	4.65e-05	0.0048	CcSEcCtD
Benzphetamine—Palpitations—Doxorubicin—pancreatic cancer	4.59e-05	0.00474	CcSEcCtD
Benzphetamine—Dizziness—Docetaxel—pancreatic cancer	4.5e-05	0.00464	CcSEcCtD
Benzphetamine—Tachycardia—Epirubicin—pancreatic cancer	4.48e-05	0.00462	CcSEcCtD
Benzphetamine—Hyperhidrosis—Epirubicin—pancreatic cancer	4.43e-05	0.00458	CcSEcCtD
Benzphetamine—Anorexia—Epirubicin—pancreatic cancer	4.37e-05	0.00451	CcSEcCtD
Benzphetamine—Headache—Docetaxel—pancreatic cancer	4.26e-05	0.0044	CcSEcCtD
Benzphetamine—Insomnia—Epirubicin—pancreatic cancer	4.15e-05	0.00428	CcSEcCtD
Benzphetamine—Tachycardia—Doxorubicin—pancreatic cancer	4.14e-05	0.00428	CcSEcCtD
Benzphetamine—Hyperhidrosis—Doxorubicin—pancreatic cancer	4.1e-05	0.00424	CcSEcCtD
Benzphetamine—Anorexia—Doxorubicin—pancreatic cancer	4.04e-05	0.00418	CcSEcCtD
Benzphetamine—Nausea—Docetaxel—pancreatic cancer	4.04e-05	0.00417	CcSEcCtD
Benzphetamine—Dyspepsia—Epirubicin—pancreatic cancer	4.04e-05	0.00417	CcSEcCtD
Benzphetamine—Decreased appetite—Epirubicin—pancreatic cancer	3.99e-05	0.00412	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Epirubicin—pancreatic cancer	3.96e-05	0.00409	CcSEcCtD
Benzphetamine—Insomnia—Doxorubicin—pancreatic cancer	3.84e-05	0.00396	CcSEcCtD
Benzphetamine—Dyspepsia—Doxorubicin—pancreatic cancer	3.73e-05	0.00386	CcSEcCtD
Benzphetamine—Decreased appetite—Doxorubicin—pancreatic cancer	3.69e-05	0.00381	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	3.66e-05	0.00378	CcSEcCtD
Benzphetamine—Urticaria—Epirubicin—pancreatic cancer	3.64e-05	0.00376	CcSEcCtD
Benzphetamine—Hypersensitivity—Epirubicin—pancreatic cancer	3.38e-05	0.00349	CcSEcCtD
Benzphetamine—Urticaria—Doxorubicin—pancreatic cancer	3.37e-05	0.00348	CcSEcCtD
Benzphetamine—Diarrhoea—Epirubicin—pancreatic cancer	3.14e-05	0.00324	CcSEcCtD
Benzphetamine—Hypersensitivity—Doxorubicin—pancreatic cancer	3.13e-05	0.00323	CcSEcCtD
Benzphetamine—Dizziness—Epirubicin—pancreatic cancer	3.03e-05	0.00313	CcSEcCtD
Benzphetamine—Diarrhoea—Doxorubicin—pancreatic cancer	2.9e-05	0.003	CcSEcCtD
Benzphetamine—Headache—Epirubicin—pancreatic cancer	2.87e-05	0.00297	CcSEcCtD
Benzphetamine—Dizziness—Doxorubicin—pancreatic cancer	2.81e-05	0.0029	CcSEcCtD
Benzphetamine—Nausea—Epirubicin—pancreatic cancer	2.72e-05	0.00281	CcSEcCtD
Benzphetamine—Headache—Doxorubicin—pancreatic cancer	2.66e-05	0.00274	CcSEcCtD
Benzphetamine—Nausea—Doxorubicin—pancreatic cancer	2.52e-05	0.0026	CcSEcCtD
Benzphetamine—ADRA1A—Signaling Pathways—SSTR2—pancreatic cancer	4.61e-06	0.000837	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—SST—pancreatic cancer	4.55e-06	0.000825	CbGpPWpGaD
Benzphetamine—ADRA2A—Platelet activation, signaling and aggregation—SRC—pancreatic cancer	4.53e-06	0.000822	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—CNR1—pancreatic cancer	4.51e-06	0.000819	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—PTCH1—pancreatic cancer	4.51e-06	0.000819	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—PTHLH—pancreatic cancer	4.51e-06	0.000819	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CCKBR—pancreatic cancer	4.45e-06	0.000808	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—SSTR1—pancreatic cancer	4.45e-06	0.000807	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—SST—pancreatic cancer	4.44e-06	0.000806	CbGpPWpGaD
Benzphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	4.43e-06	0.000804	CbGpPWpGaD
Benzphetamine—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—pancreatic cancer	4.41e-06	0.000801	CbGpPWpGaD
Benzphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—pancreatic cancer	4.37e-06	0.000793	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—PPY—pancreatic cancer	4.36e-06	0.000792	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—TYMP—pancreatic cancer	4.36e-06	0.000791	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—GCG—pancreatic cancer	4.36e-06	0.000791	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—SSTR2—pancreatic cancer	4.28e-06	0.000777	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—PLAU—pancreatic cancer	4.28e-06	0.000776	CbGpPWpGaD
Benzphetamine—ADRA1A—G alpha (q) signalling events—PIK3CA—pancreatic cancer	4.24e-06	0.00077	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—CNR1—pancreatic cancer	4.19e-06	0.000761	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—DTX4—pancreatic cancer	4.19e-06	0.00076	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—GLI1—pancreatic cancer	4.19e-06	0.00076	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—AGTR1—pancreatic cancer	4.16e-06	0.000755	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CCKBR—pancreatic cancer	4.14e-06	0.000751	CbGpPWpGaD
Benzphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—pancreatic cancer	4.13e-06	0.000749	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—SST—pancreatic cancer	4.13e-06	0.000749	CbGpPWpGaD
Benzphetamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	4.11e-06	0.000747	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—CNR1—pancreatic cancer	4.1e-06	0.000744	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—NRP1—pancreatic cancer	4.07e-06	0.000739	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—PPP2R5B—pancreatic cancer	4.07e-06	0.000739	CbGpPWpGaD
Benzphetamine—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—pancreatic cancer	4.05e-06	0.000735	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—GCG—pancreatic cancer	4.05e-06	0.000735	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—GCG—pancreatic cancer	3.96e-06	0.000718	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—HEY2—pancreatic cancer	3.92e-06	0.000711	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—DTX4—pancreatic cancer	3.89e-06	0.000706	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—GLI1—pancreatic cancer	3.89e-06	0.000706	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—AGTR1—pancreatic cancer	3.86e-06	0.000701	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—GAST—pancreatic cancer	3.83e-06	0.000695	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—CNR1—pancreatic cancer	3.81e-06	0.000691	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—PIK3CG—pancreatic cancer	3.81e-06	0.00069	CbGpPWpGaD
Benzphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—pancreatic cancer	3.79e-06	0.000688	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—PPP2R5B—pancreatic cancer	3.78e-06	0.000687	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—NRP1—pancreatic cancer	3.78e-06	0.000687	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—AGTR1—pancreatic cancer	3.78e-06	0.000685	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—EGF—pancreatic cancer	3.76e-06	0.000682	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—GLP1R—pancreatic cancer	3.75e-06	0.00068	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—DPYD—pancreatic cancer	3.69e-06	0.000669	CbGpPWpGaD
Benzphetamine—SLC6A3—Neuronal System—HRAS—pancreatic cancer	3.68e-06	0.000668	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—GCG—pancreatic cancer	3.68e-06	0.000668	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—HEY2—pancreatic cancer	3.64e-06	0.000661	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—HEY1—pancreatic cancer	3.63e-06	0.000659	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—SCT—pancreatic cancer	3.63e-06	0.000659	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—GAST—pancreatic cancer	3.56e-06	0.000646	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—GLP1R—pancreatic cancer	3.52e-06	0.000638	CbGpPWpGaD
Benzphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—pancreatic cancer	3.51e-06	0.000637	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—AGTR1—pancreatic cancer	3.51e-06	0.000637	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—SLC2A2—pancreatic cancer	3.5e-06	0.000635	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CCK—pancreatic cancer	3.46e-06	0.000628	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—DPYD—pancreatic cancer	3.46e-06	0.000628	CbGpPWpGaD
Benzphetamine—ADRA2A—Platelet activation, signaling and aggregation—PIK3CA—pancreatic cancer	3.45e-06	0.000626	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CNR2—pancreatic cancer	3.37e-06	0.000612	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—GLP1R—pancreatic cancer	3.37e-06	0.000612	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—SCT—pancreatic cancer	3.37e-06	0.000612	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—HEY1—pancreatic cancer	3.37e-06	0.000612	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR ligand binding—CXCL8—pancreatic cancer	3.37e-06	0.000612	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—PIK3CD—pancreatic cancer	3.35e-06	0.000607	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CCKAR—pancreatic cancer	3.32e-06	0.000602	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—SLC2A2—pancreatic cancer	3.28e-06	0.000595	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—JAG2—pancreatic cancer	3.22e-06	0.000584	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CCK—pancreatic cancer	3.22e-06	0.000584	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—MEN1—pancreatic cancer	3.17e-06	0.000576	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CNR2—pancreatic cancer	3.14e-06	0.000569	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—GLP1R—pancreatic cancer	3.14e-06	0.000569	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR ligand binding—CXCL8—pancreatic cancer	3.13e-06	0.000569	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CCKAR—pancreatic cancer	3.08e-06	0.00056	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—SHH—pancreatic cancer	3.03e-06	0.000549	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—NOTCH4—pancreatic cancer	3.01e-06	0.000546	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—JAG2—pancreatic cancer	2.99e-06	0.000543	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—IAPP—pancreatic cancer	2.99e-06	0.000542	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—MEN1—pancreatic cancer	2.95e-06	0.000535	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—PIK3CB—pancreatic cancer	2.92e-06	0.000529	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—PTHLH—pancreatic cancer	2.87e-06	0.000521	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—PTCH1—pancreatic cancer	2.87e-06	0.000521	CbGpPWpGaD
Benzphetamine—ADRA2A—Platelet activation, signaling and aggregation—AKT1—pancreatic cancer	2.82e-06	0.000511	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—SHH—pancreatic cancer	2.81e-06	0.00051	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—NOTCH4—pancreatic cancer	2.79e-06	0.000507	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—IAPP—pancreatic cancer	2.78e-06	0.000504	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—CD44—pancreatic cancer	2.71e-06	0.000492	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—PTCH1—pancreatic cancer	2.67e-06	0.000484	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—PTHLH—pancreatic cancer	2.67e-06	0.000484	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—SST—pancreatic cancer	2.62e-06	0.000476	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—PRSS1—pancreatic cancer	2.61e-06	0.000474	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—GCG—pancreatic cancer	2.6e-06	0.000472	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—PIK3CG—pancreatic cancer	2.59e-06	0.00047	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—JAG1—pancreatic cancer	2.57e-06	0.000466	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—NOTCH3—pancreatic cancer	2.56e-06	0.000464	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—CD44—pancreatic cancer	2.54e-06	0.000461	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—STK11—pancreatic cancer	2.44e-06	0.000443	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—SST—pancreatic cancer	2.44e-06	0.000442	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—GCG—pancreatic cancer	2.44e-06	0.000442	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CNR1—pancreatic cancer	2.42e-06	0.000439	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—PIK3CG—pancreatic cancer	2.4e-06	0.000436	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—JAG1—pancreatic cancer	2.39e-06	0.000433	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—NOTCH3—pancreatic cancer	2.38e-06	0.000431	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—PIK3CG—pancreatic cancer	2.35e-06	0.000426	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—GCG—pancreatic cancer	2.34e-06	0.000424	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—SRC—pancreatic cancer	2.34e-06	0.000424	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—STK11—pancreatic cancer	2.29e-06	0.000416	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—VEGFA—pancreatic cancer	2.28e-06	0.000413	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—PIK3CD—pancreatic cancer	2.28e-06	0.000413	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—ARG2—pancreatic cancer	2.27e-06	0.000411	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CNR1—pancreatic cancer	2.25e-06	0.000408	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—NRAS—pancreatic cancer	2.25e-06	0.000408	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—AGTR1—pancreatic cancer	2.23e-06	0.000405	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—STK11—pancreatic cancer	2.2e-06	0.000399	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—PIK3CG—pancreatic cancer	2.18e-06	0.000396	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—GCG—pancreatic cancer	2.17e-06	0.000394	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—PIK3CD—pancreatic cancer	2.11e-06	0.000384	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—TYMS—pancreatic cancer	2.1e-06	0.000381	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—TGFB1—pancreatic cancer	2.09e-06	0.000379	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—AGTR1—pancreatic cancer	2.07e-06	0.000376	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—PIK3CD—pancreatic cancer	2.07e-06	0.000375	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—STK11—pancreatic cancer	2.04e-06	0.000371	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—PIK3CB—pancreatic cancer	1.98e-06	0.00036	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—TYMP—pancreatic cancer	1.98e-06	0.00036	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—TYMS—pancreatic cancer	1.97e-06	0.000358	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—KRAS—pancreatic cancer	1.93e-06	0.000351	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—SMAD4—pancreatic cancer	1.93e-06	0.000349	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—PIK3CD—pancreatic cancer	1.92e-06	0.000348	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—CXCL8—pancreatic cancer	1.91e-06	0.000346	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—HES1—pancreatic cancer	1.88e-06	0.000341	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—PIK3CB—pancreatic cancer	1.84e-06	0.000334	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—PIK3CB—pancreatic cancer	1.8e-06	0.000327	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—SMAD4—pancreatic cancer	1.79e-06	0.000325	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—PIK3CA—pancreatic cancer	1.78e-06	0.000323	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—CXCL8—pancreatic cancer	1.77e-06	0.000321	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—HES1—pancreatic cancer	1.75e-06	0.000317	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—CXCL8—pancreatic cancer	1.73e-06	0.000314	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—TP53—pancreatic cancer	1.72e-06	0.000312	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—APOE—pancreatic cancer	1.71e-06	0.00031	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—PIK3CB—pancreatic cancer	1.67e-06	0.000304	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—TERT—pancreatic cancer	1.65e-06	0.000299	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—HRAS—pancreatic cancer	1.64e-06	0.000298	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—CXCL8—pancreatic cancer	1.61e-06	0.000292	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—APOE—pancreatic cancer	1.6e-06	0.000291	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—GLP1R—pancreatic cancer	1.6e-06	0.00029	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—HIF1A—pancreatic cancer	1.58e-06	0.000286	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—TSC2—pancreatic cancer	1.57e-06	0.000285	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—DPYD—pancreatic cancer	1.57e-06	0.000285	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—PIK3CG—pancreatic cancer	1.54e-06	0.00028	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—APOE—pancreatic cancer	1.54e-06	0.000279	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—TERT—pancreatic cancer	1.53e-06	0.000278	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—KDR—pancreatic cancer	1.51e-06	0.000273	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	1.49e-06	0.000271	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—PPARG—pancreatic cancer	1.49e-06	0.00027	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—HIF1A—pancreatic cancer	1.46e-06	0.000266	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—TSC2—pancreatic cancer	1.46e-06	0.000265	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—AKT1—pancreatic cancer	1.45e-06	0.000263	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—PIK3CG—pancreatic cancer	1.45e-06	0.000262	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—NFKBIA—pancreatic cancer	1.43e-06	0.00026	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—APOE—pancreatic cancer	1.43e-06	0.000259	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—NOTCH1—pancreatic cancer	1.42e-06	0.000258	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—KDR—pancreatic cancer	1.4e-06	0.000254	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—PPARG—pancreatic cancer	1.4e-06	0.000253	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—PIK3CG—pancreatic cancer	1.39e-06	0.000252	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—NRAS—pancreatic cancer	1.39e-06	0.000252	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—EGF—pancreatic cancer	1.37e-06	0.000249	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—PIK3CD—pancreatic cancer	1.36e-06	0.000246	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—NFKBIA—pancreatic cancer	1.33e-06	0.000242	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—NOTCH1—pancreatic cancer	1.32e-06	0.000239	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—PIK3CG—pancreatic cancer	1.29e-06	0.000234	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—NRAS—pancreatic cancer	1.29e-06	0.000234	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—EGF—pancreatic cancer	1.28e-06	0.000231	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—PIK3CD—pancreatic cancer	1.27e-06	0.000231	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—EGFR—pancreatic cancer	1.26e-06	0.00023	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—PIK3CD—pancreatic cancer	1.22e-06	0.000221	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.21e-06	0.000219	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—KRAS—pancreatic cancer	1.19e-06	0.000217	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—PIK3CB—pancreatic cancer	1.18e-06	0.000215	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—EGFR—pancreatic cancer	1.18e-06	0.000213	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—PTGS2—pancreatic cancer	1.17e-06	0.000213	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—CD44—pancreatic cancer	1.15e-06	0.00021	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—PIK3CD—pancreatic cancer	1.13e-06	0.000206	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.12e-06	0.000204	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—KRAS—pancreatic cancer	1.11e-06	0.000201	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—PIK3CB—pancreatic cancer	1.11e-06	0.000201	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—GCG—pancreatic cancer	1.11e-06	0.000201	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—PTGS2—pancreatic cancer	1.1e-06	0.000199	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—PIK3CA—pancreatic cancer	1.1e-06	0.000199	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—PIK3CB—pancreatic cancer	1.06e-06	0.000193	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—STK11—pancreatic cancer	1.04e-06	0.000189	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CXCL8—pancreatic cancer	1.02e-06	0.000186	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—PTEN—pancreatic cancer	1.02e-06	0.000185	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—PIK3CA—pancreatic cancer	1.02e-06	0.000185	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—HRAS—pancreatic cancer	1.02e-06	0.000184	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—PIK3CB—pancreatic cancer	9.88e-07	0.000179	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—AKT1—pancreatic cancer	9.88e-07	0.000179	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CASP3—pancreatic cancer	9.79e-07	0.000178	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—PTEN—pancreatic cancer	9.58e-07	0.000174	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CCND1—pancreatic cancer	9.52e-07	0.000173	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CXCL8—pancreatic cancer	9.5e-07	0.000172	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—HRAS—pancreatic cancer	9.44e-07	0.000171	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CTNNB1—pancreatic cancer	9.43e-07	0.000171	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—MMP9—pancreatic cancer	9.25e-07	0.000168	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—PTEN—pancreatic cancer	9.19e-07	0.000167	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—AKT1—pancreatic cancer	9.18e-07	0.000167	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CASP3—pancreatic cancer	9.09e-07	0.000165	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—AKT1—pancreatic cancer	8.97e-07	0.000163	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—TYMS—pancreatic cancer	8.96e-07	0.000162	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CCND1—pancreatic cancer	8.85e-07	0.000161	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CTNNB1—pancreatic cancer	8.76e-07	0.000159	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—MMP9—pancreatic cancer	8.59e-07	0.000156	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—PTEN—pancreatic cancer	8.54e-07	0.000155	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—SRC—pancreatic cancer	8.53e-07	0.000155	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—AKT1—pancreatic cancer	8.33e-07	0.000151	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—VEGFA—pancreatic cancer	8.3e-07	0.000151	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—STAT3—pancreatic cancer	8.22e-07	0.000149	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—NRAS—pancreatic cancer	8.2e-07	0.000149	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—SRC—pancreatic cancer	7.92e-07	0.000144	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—VEGFA—pancreatic cancer	7.72e-07	0.00014	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—MYC—pancreatic cancer	7.64e-07	0.000139	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—STAT3—pancreatic cancer	7.64e-07	0.000139	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—TGFB1—pancreatic cancer	7.62e-07	0.000138	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—NRAS—pancreatic cancer	7.62e-07	0.000138	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—EGFR—pancreatic cancer	7.47e-07	0.000136	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—APOE—pancreatic cancer	7.28e-07	0.000132	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—PIK3CA—pancreatic cancer	7.21e-07	0.000131	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—MYC—pancreatic cancer	7.1e-07	0.000129	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—TGFB1—pancreatic cancer	7.08e-07	0.000128	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—KRAS—pancreatic cancer	7.06e-07	0.000128	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—EGFR—pancreatic cancer	6.94e-07	0.000126	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—PIK3CA—pancreatic cancer	6.76e-07	0.000123	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	6.57e-07	0.000119	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—KRAS—pancreatic cancer	6.56e-07	0.000119	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—PIK3CA—pancreatic cancer	6.49e-07	0.000118	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—PPARG—pancreatic cancer	6.34e-07	0.000115	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—TP53—pancreatic cancer	6.27e-07	0.000114	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—PIK3CA—pancreatic cancer	6.03e-07	0.000109	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—HRAS—pancreatic cancer	6e-07	0.000109	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—AKT1—pancreatic cancer	5.89e-07	0.000107	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—TP53—pancreatic cancer	5.83e-07	0.000106	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	5.78e-07	0.000105	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—HRAS—pancreatic cancer	5.58e-07	0.000101	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—AKT1—pancreatic cancer	5.52e-07	0.0001	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—AKT1—pancreatic cancer	5.3e-07	9.61e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	5.04e-07	9.14e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—PTGS2—pancreatic cancer	4.99e-07	9.05e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—AKT1—pancreatic cancer	4.92e-07	8.93e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—PTEN—pancreatic cancer	4.35e-07	7.9e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	3.07e-07	5.57e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—AKT1—pancreatic cancer	2.51e-07	4.55e-05	CbGpPWpGaD
